Mike Spillner has over 25 years of experience as an IP attorney, both as in-house legal counsel and as a partner at a global Am Law 50 firm.
He is currently the Head of Government Affairs and Public Policy at Adeia Inc., a U.S.-based, publicly-traded (NASDAQ: ADEA) research and development company that invents and develops next-generation technologies for the media and semiconductor industries. Adeia is among the most innovative companies in America, ranking in the Top 75 organizations granted the most patents by the U.S. Patent and Trademark Office in 2024.
He spent the first 15 years of his career at Orrick Herrington & Sutcliffe LLP, where he was a partner in the firm’s IP litigation group. He attended Stanford Law School, and earned his undergraduate degree from UCLA.
At first glance, certain comments by U.S. Patent and Trademark Office (USPTO) Director nominee John Squires during his Senate Judiciary Committee confirmation hearing raised questions about whether he sees the Patent Trial and Appeal Board (PTAB) in the same way as Acting Director Coke Morgan Stewart. But on closer examination, and when viewed in context, Squires’s comments could reflect alignment not only with Acting Director Stewart, but with Congress’s objective when it passed the Leahy-Smith America Invents Act (AIA) — that patent quality be vetted as early as possible, during or shortly after examination, and that later, back-end challenges only be available in limited circumstances.